A recent study has revealed that a widely used anti-aging drug combination, previously thought to be beneficial, may have detrimental effects on brain health by stripping myelin from neurons. Researchers found that this unexpected outcome raises serious questions about the long-term safety of these compounds, which have gained popularity in the longevity and healthspan fields.

This finding is particularly significant as it highlights the need for rigorous evaluation of anti-aging therapeutics. Myelin is crucial for efficient neural signaling, and its loss could lead to cognitive decline and other neurological issues. As the market for longevity interventions grows, understanding the full spectrum of their effects on brain health becomes essential for both researchers and clinicians.

The implications of this study underscore the importance of comprehensive safety assessments in the development of anti-aging therapies. For a deeper dive into the research and its potential impact on the field, I encourage you to read the full article.

Source: news.google.com